DrugDashboards

Market view

riluzole · Liquid

4 marketed package NDCs · 2 active manufacturers

Most dispensed: 50 mg · Tablet, Film Coated · #60 tablet, film coateds/bottle · 50 mg · Tablet · #60 tablets/bottle · 5 mg/mL · Liquid · #300 mL/bottle, plastic

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “requirements related to complying with good manufacturing practices.

What changed in the last 90 days

Every detected change for riluzole, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • RiluzoleSep 2, 2026
    Mfr exited
    Farmak, A.s. · riluzole
  • RiluzoleAug 26, 2026
    Mfr entered
    CZECH-GEN, a.s. · riluzole
  • RiluzoleAug 26, 2026
    Product update
    labeler name: FARMAK, A.S. → CZECH-GEN, a.s.
  • RiluzoleAug 26, 2026
    Product update
    labeler name: FARMAK, A.S. → CZECH-GEN, a.s.
  • RiluzoleAug 19, 2026
    Price down
    NADAC $0.29254 → $0.28379 per unit (-2.99%)
  • riluzoleAug 19, 2026
    Price down
    NADAC $0.29254 → $0.28379 per unit (-2.99%)
  • RiluzoleAug 19, 2026
    Price down
    NADAC $0.29254 → $0.28379 per unit (-2.99%)
  • TiglutikAug 1, 2026
    Mfr entered
    Italfarmaco SPA · riluzole
  • TiglutikAug 1, 2026
    New product
    Italfarmaco SPA
  • riluzoleJul 22, 2026
    Price down
    NADAC $0.29448 → $0.29254 per unit (-0.66%)

Common questions

Is Riluzole in shortage right now?
Yes. FDA currently lists Riluzole in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Riluzole?
15 companies have marketed Riluzole in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Riluzole cost?
The typical pharmacy pays about $0.2838 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

  • In shortage nowTeglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)Jan 26, 2024
  • In shortage nowTeglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)Jan 26, 2024
  • In shortage nowTeglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)Jan 26, 2024
  • In shortage nowTiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)Jan 26, 2024

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.